Home Newsfeeds BMO Capital Maintains Outperform on Stride, Raises Price Target to $48

BMO Capital Maintains Outperform on Stride, Raises Price Target to $48

BMO Capital analyst Jeffrey Silber maintains Stride (NYSE:LRN) with a Outperform and raises the price target from $47 to $48.

January 26, 2023

1 minute read

BMO Capital analyst Jeffrey Silber maintains Stride (NYSE:LRN) with a Outperform and raises the price target from $47 to $48.

Why Tesla Stock Is Pulling Back Premarket Today

April 10, 7:50 AM

Tesla, Inc. (NASDAQ:TSLA) shares fell in premarket trading on Monday, reflecting the negative momentum since the electric vehicle company released…

February 21, 7:10 AM

HC Wainwright & Co. analyst Ed Arce reiterates Travere Therapeutics (NASDAQ:TVTX) with a Buy and raises the price target from $36 to $40.

July 14, 9:45 AM

Morgan Stanley analyst Adam Jonas maintains QuantumScape (NYSE:QS) with a Equal-Weight and lowers the price target from $30 to $12.

May 12, 1:57 PM

Needham analyst Kyle Peterson initiated coverage on TriNet Group Inc (NYSE:TNET) at a Buy rating and a price target of $115. The analyst…